Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years
McFarland DC, Naikan J, Rozenblit M, Mandeli J, Bleiweiss I, Tiersten A. Changes in Pathological Complete Response Rates after Neoadjuvant Chemotherapy for Breast Carcinoma over Five Years. Journal Of Oncology 2016, 2016: 4324863. PMID: 27382369, PMCID: PMC4921638, DOI: 10.1155/2016/4324863.Peer-Reviewed Original ResearchPathological complete response rateTriple-negative breast cancerComplete response rateNeoadjuvant chemotherapyRates of pCRTime period 2PCR rateResponse rateAnthracycline/taxaneDual HER2 blockadeIntroduction of carboplatinType of chemotherapyBreast cancer patientsNegative breast cancerTime period 1HER2 blockadeNeoadjuvant regimensAdjuvant regimensClinical characteristicsHER2 positivityOpportunity trialCancer patientsBreast carcinomaBreast cancerStage I